within Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GX02_Levocabastine;

model Levocabastine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 9.722222222222224e-07,
    adminDuration = 600,
    adminMass = 0.54 / 1000000,
    adminCount = 1,
    Vd = 0.0013,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Levocabastine</td></tr><tr><td>ATC code:</td><td>S01GX02</td></tr><td>route:</td><td>ocular</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.54</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.3</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.05</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Levocabastine is a selective second-generation histamine H1 receptor antagonist used primarily as an ophthalmic solution for symptomatic relief of allergic conjunctivitis. It is administered topically and has minimal systemic effects due to low absorption. Levocabastine is approved in some countries for ocular and intranasal use for allergic symptoms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after ocular administration.</p><h4>References</h4><ol><li><p>Heykants, J, et al., &amp; Woestenborghs, R (1995). The pharmacokinetic properties of topical levocabastine. A review. <i>Clinical pharmacokinetics</i> 29(4) 221–230. DOI:<a href=\"https://doi.org/10.2165/00003088-199529040-00002\">10.2165/00003088-199529040-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8549024/\">https://pubmed.ncbi.nlm.nih.gov/8549024</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S01GX02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Levocabastine;
